Company: DERM
Filing Date: 2025-08-28
Form Type: 424B3
Source: 0001104659-25-084876
Chunk: 32

Company: Journey Medical Corp
Filing Date: 2025-08-28
Form: 424B3
Chunk 32
---
. The risks and uncertainties described in the documents incorporated by reference herein are not the only risks
and uncertainties that you may face.

For more information about our SEC filings, please
see “Where You Can Find More Information” and “Incorporation of Certain Information by Reference.”

<div align='center'>5

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

Certain matters discussed
in this prospectus, including the documents that we incorporate by reference, may constitute forward-looking statements for purposes of
the Securities Act of 1933, as amended (the “Securities Act”) and the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements
to be materially different from the future results, performance or achievements expressed or implied by such forward-looking statements.
The words “plan,” “predict,” “potential,” “continue,” “anticipate,” “believe,”
“estimate,” “may,” “expect,” “will,” “could,” “project,” “intend”
and similar expressions are generally intended to identify forward-looking statements. Our actual results may differ materially from the
results anticipated in these forward-looking statements due to a variety of factors, including, without limitation, those discussed under
the captions “Risk Factors,” and elsewhere in this report. All written or oral forward-looking statements attributable
to us are expressly qualified in their entirety by these cautionary statements. Such forward-looking statements include, but are not limited
to, statements about:

| · | our future financial performance, including our expectations regarding our revenue, cost and operating                                  
 expenses, including changes in technology and development, selling and marketing and general and administrative expenses, gross profit, 
 and our ability to achieve, and maintain, future profitability;                                                                         |

| · | our business plan and our ability to effectively manage our growth; |

| · | economic and industry trends, projected growth, or trend analysis; |

| · | political, economic, legal, social and health risks, including the COVID-19 pandemic and subsequent public          
 health measures that may affect our business or the global economy and the actions we may take in response thereto; |

| · | developments and projections relating to our competitors and industry; |

| · | increases in costs and disruption of supply or shortage of raw materials; |

| · | our and our licensors’ ability to obtain, establish, maintain, protect and enforce intellectual